0001437749-18-001220.txt : 20180126
0001437749-18-001220.hdr.sgml : 20180126
20180126163040
ACCESSION NUMBER: 0001437749-18-001220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180124
FILED AS OF DATE: 20180126
DATE AS OF CHANGE: 20180126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Altieri Richard M.
CENTRAL INDEX KEY: 0001592351
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 18552275
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-01-24
0001586049
Oxford Immunotec Global PLC
OXFD
0001592351
Altieri Richard M.
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
Chief Financial Officer
Ordinary Shares
2018-01-24
4
M
0
152330
0.18
A
202965
D
Share Option (Right to Buy)
0.18
2018-01-24
4
M
0
152330
0
D
2022-03-31
Ordinary Shares
152330
0
D
Options became fully exercisable on March 31, 2016.
/s/ Elizabeth Keiley, as Attorney-in-Fact for Richard Altieri
2018-01-26